News stories about Clorox (NYSE:CLX) have trended somewhat positive on Wednesday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Clorox earned a coverage optimism score of 0.20 on Accern’s scale. Accern also gave headlines about the company an impact score of 46.3580780848173 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.
These are some of the headlines that may have impacted Accern Sentiment Analysis’s scoring:
- Clorox Has Magically Added $4 Billion in Market Cap This Year — Here’s How (finance.yahoo.com)
- Consumer-Goods Firms Shine in Financial Category — WSJ (ih.advfn.com)
- Cramer: Tech Is Out of Favor, but It Doesn’t Deserve to Be (finance.yahoo.com)
- Why The Clorox Company Stock Jumped 10.1% in November (finance.yahoo.com)
- Bridgeway Capital Management Has Increased By $837900 Its Clorox Co Del (CLX) Stake; First Manhattan Company … – Hill Country Times (hillcountrytimes.com)
CLX has been the subject of several recent research reports. Jefferies Group reiterated a “hold” rating and issued a $137.00 price objective (up previously from $136.00) on shares of Clorox in a research note on Wednesday, August 9th. BMO Capital Markets reiterated an “outperform” rating on shares of Clorox in a research note on Tuesday, September 12th. Zacks Investment Research lowered Clorox from a “hold” rating to a “sell” rating in a research report on Wednesday, October 4th. Royal Bank Of Canada reissued a “hold” rating and set a $115.00 target price on shares of Clorox in a research report on Sunday, October 8th. Finally, Morgan Stanley cut their target price on Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 2nd. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $128.72.
Clorox (NYSE:CLX) traded up $0.39 on Wednesday, reaching $145.05. The company’s stock had a trading volume of 839,082 shares, compared to its average volume of 816,923. The firm has a market capitalization of $18,436.93, a price-to-earnings ratio of 25.76, a price-to-earnings-growth ratio of 3.89 and a beta of 0.43. Clorox has a 52 week low of $113.95 and a 52 week high of $145.32. The company has a debt-to-equity ratio of 3.02, a quick ratio of 0.77 and a current ratio of 1.10.
Clorox (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.41 by $0.05. The company had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.48 billion. Clorox had a return on equity of 161.59% and a net margin of 11.84%. The firm’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.36 earnings per share. sell-side analysts predict that Clorox will post 5.6 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 2.32%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s dividend payout ratio (DPR) is 61.88%.
In other Clorox news, SVP Michael R. Costello sold 10,574 shares of Clorox stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $136.01, for a total value of $1,438,169.74. Following the transaction, the senior vice president now directly owns 34,867 shares in the company, valued at approximately $4,742,260.67. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Matthew T. Laszlo sold 20,051 shares of Clorox stock in a transaction that occurred on Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares in the company, valued at $1,421,492.16. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Clorox (CLX) Stock Price” was first reported by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of United States and international copyright and trademark legislation. The correct version of this piece of content can be accessed at https://ledgergazette.com/2017/12/06/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-clorox-clx-stock-price.html.
Clorox Company Profile
The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.
Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.